Oxymetazoline Hydrochloride 12-Hour
NDC 51672-2030, Oxymetazoline Hydrochloride, spray, from Sun Pharmaceutical Industries, Inc..
- Product NDC
- 51672-2030
- Status
- Listed
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- SPRAY
- Route
- NASAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51672-2030 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXYMETAZOLINE HYDROCHLORIDE.05 g/100mL
Pharmacologic classes
Imidazolines [CS]; Increased Sympathetic Activity [PE]; Vasoconstriction [PE]; Vasoconstrictor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51672-2030-3 | 51672203003 | 1 BOTTLE, SPRAY in 1 CARTON (51672-2030-3) / 30 mL in 1 BOTTLE, SPRAY |
| 51672-2030-5 | 51672203005 | 1 BOTTLE, SPRAY in 1 CARTON (51672-2030-5) / 15 mL in 1 BOTTLE, SPRAY |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 51672-2030 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51672-2030 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51672-2030. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.